<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01237509</url>
  </required_header>
  <id_info>
    <org_study_id>Soevn01</org_study_id>
    <nct_id>NCT01237509</nct_id>
  </id_info>
  <brief_title>EEG Changes of type1 Diabetes During Sleep -Insulin Induced Hypoglycemia</brief_title>
  <acronym>sleep</acronym>
  <official_title>Registration of EEG Changes During Sleep Associated With Insulin Induced Hypoglycemia in Type 1 Diabetic</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>UNEEG Medical A/S</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>UNEEG Medical A/S</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hypoglycaemia is associated with characteristic changes in the EEG with the appearance of&#xD;
      slow frequency waves. In a recent study the investigators have shown that these changes can&#xD;
      be recorded from subcutaneous electrodes and processed by an automated mathematical algorithm&#xD;
      based on non-linear spectral analysis, and that changes are present before the occurrence of&#xD;
      severe hypoglycaemia in type 1 diabetes patients. An alarm device based on real-time analysis&#xD;
      of continuous EEG-recordings may thus be possible. For many diabetes patients nocturnal&#xD;
      hypoglycaemia is a feared complication which may thus be preventable.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The different sleep stages are associated with specific EEG-changes of high complexity with&#xD;
      the occurrence of slow frequency waves during stages of deep sleep.&#xD;
&#xD;
      The aim of this study is to assess EEG changes during insulin-induced hypoglycaemia in type 1&#xD;
      diabetes patients in the different stages of sleep. The core questions will be:&#xD;
&#xD;
      (i) Will the pathological hypoglycaemia-related EEG-changes dominate over the physiological&#xD;
      sleep-related changes when hypoglycaemia occurs during sleep? (ii) Is it possible to refine&#xD;
      the mathematical algorithm to an extend, where EEG-changes during hypoglycaemia can be&#xD;
      distinguished from sleep-related EEG-changes in all sleep stages.&#xD;
&#xD;
      (iii) If so, at what blood-glucose level will hypoglycaemia associated EEG-changes be&#xD;
      detectable and (iv) Will patients be able to react adequately by ingestion of carbohydrates&#xD;
      if an alarm can is given at the time of hypoglycaemia associates EEG-changes.&#xD;
&#xD;
      Twelve patients with type 1 diabetes will be studied. EEG will be recorded during graded&#xD;
      hypoglycaemia achieved by insulin infusion and frequent glucose measurements. EEG will be&#xD;
      analysed by the automated algorithm and by visual analysis to address the questions (i), (ii)&#xD;
      and (iii). To address question (iv) real-time EEG-analysis with a predefined threshold&#xD;
      defining hypoglycaemia will be performed and an alarm will aim to warn the patients of&#xD;
      impeding hypoglycaemia. Patients will be asked to consume carbohydrates at alarm.&#xD;
&#xD;
      During the experiments the patients will be under continuous observation.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2009</start_date>
  <completion_date type="Actual">June 2010</completion_date>
  <primary_completion_date type="Actual">February 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Hypoglycaemia associated EEG changes during sleep</measure>
    <time_frame>24 hours</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">10</enrollment>
  <condition>Sleep EEG</condition>
  <arm_group>
    <arm_group_label>group1</arm_group_label>
    <description>Patients with T1D</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Hypo device</intervention_name>
    <arm_group_label>group1</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Type 1 diabetes&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Type 1 diabetes patients&#xD;
&#xD;
          -  Hypoglycemia unawareness&#xD;
&#xD;
          -  aged 18-70&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Severe cardiac disease&#xD;
&#xD;
               -  History of myocardial infarction&#xD;
&#xD;
               -  Cardiac arrhythmia&#xD;
&#xD;
          -  Previous stroke or cerebral haemorrhage and any other structural cerebral disease&#xD;
&#xD;
          -  Active cancer or cancer diagnosis within the past five years&#xD;
&#xD;
          -  Uremia defined as s-creatinine above 3 times upper reference value&#xD;
&#xD;
          -  Liver disease defined as s-ALAT above 3 times upper reference interval&#xD;
&#xD;
          -  Inability to understand the informed consent&#xD;
&#xD;
          -  Epilepsy&#xD;
&#xD;
          -  Use of antiepileptic drugs for any purposes&#xD;
&#xD;
          -  Clinical important hearing impairment&#xD;
&#xD;
          -  Use of active implantable medical device including&#xD;
&#xD;
               -  Pacemaker and ICD-unit&#xD;
&#xD;
               -  Cochlear implant&#xD;
&#xD;
          -  Use of following drugs&#xD;
&#xD;
               -  Chemotherapeutic drugs of any kind&#xD;
&#xD;
               -  Methotrexate&#xD;
&#xD;
               -  Third generation antipsychotic drugs (aripiprazole, quetiapine, clozapine,&#xD;
                  ziprasidone, paliperidone, risperidone, sertindole, amisulpride, olanzapine)&#xD;
&#xD;
          -  Abuse of alcohol (defined as consumption of &gt; 250g alcohol (in Danish: 21 &quot;genstande&quot;)&#xD;
             per week or abuse of any other neuroactive substances&#xD;
&#xD;
          -  Infection at the site of device-implantation&#xD;
&#xD;
          -  Any hemorrhagic disease&#xD;
&#xD;
          -  Diving (snorkel diving allowed) or parachute jumping&#xD;
&#xD;
          -  Patients that are judged incapable of understanding the patient information or who are&#xD;
             not capable of carrying through the investigation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Esbjerg Sygehus</name>
      <address>
        <city>Esbjerg</city>
        <zip>6700</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>November 2010</verification_date>
  <study_first_submitted>November 8, 2010</study_first_submitted>
  <study_first_submitted_qc>November 8, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 9, 2010</study_first_posted>
  <last_update_submitted>March 19, 2015</last_update_submitted>
  <last_update_submitted_qc>March 19, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 20, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>EEG</keyword>
  <keyword>Sleep</keyword>
  <keyword>device</keyword>
  <keyword>diabetes</keyword>
  <keyword>hypoglycemia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypoglycemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

